Bill would free up $1B in FDA fees; Shionogi wants women to talk about dyspareunia; Sun Pharma recalls some Nimodine;

@FiercePharma: Peace treaty in Vivus proxy war: $VVUS hands board control to rebels, with new CEO Zook poised to step in. Report | Follow @FiercePharma

 @EricPFierce: From ABC's appointment of Jenny McCarthy sparks media furor. Story | Follow @EricPFierce

 @CarlyHFierce: Vivus, First Manhattan reach agreement - Wilson out as CEO and 6 FMC candidates join board. Article | Follow @CarlyHFierce

> A bipartisan bill in Congress would free up about $1 billion in user fees that the FDA could use to do its work. Story | More from FierceMedicalDevices

> Perrigo ($PRGO) said today that the FDA has given it tentative approval to make a generic version of Novo Nordisk's ($NVO) Type 2 diabetes pill Prandin. Release

> India's Sun Pharma has recalled lots of brain haemorrhage drug Nimodine in the U.S. due to "crystallisation.'' Report

> Astellas Pharma has launched its advanced prostate cancer drug Xtandi  in the U.K. Report

Medical Device News

@FierceMedDev: Stryker's sales up 5%, but recalls swallow profits. Report | Follow @FierceMedDev

 @MarkHFierce: ArthroCare's ex-CEO and former CFO both face multiple charges in a $400M fraud scheme. ICYMI yesterday | Follow @MarkHFierce

@DamianFierce: A House group has introduced the FDA SOS Act, designed to save user fees from sequester cuts. Report | Follow @DamianFierce

> LabCorp lowers outlook as profits slide. Article

> Intuitive's surgical robot juggernaut shows some cracks in Q2. More

> Hologic CEO resigns, citing personal reasons. Item

Biotech News

@FierceBiotech: $1.3B VC cash surge buoys biotech as analysts point to a rebound. More | Special Report: The Top 15 Biotech VC firms | Follow @FierceBiotech

 @JohnCFierce: Novartis buries a PhIII kidney cancer failure behind Q2 successes. News | Follow @JohnCFierce

@RyanMFierce: After Nobel Prize, Japan wants to take lead in iPSC therapy with approval of clinical trial. Article | Follow @RyanMFierce

 @EmilyMFierce: The latest at Revalesio drug alters Alzheimer's progression in animal model. Story | Follow @EmilyMFierce

> Japan green-lights trial for adult stem cell therapy for eye disease. More

> U.K. pharma group's cannabis-based diabetes drug sparks insulin output. More

> Report: Pfizer backs off Onyx bid as price gets too rich. Article

And Finally... Shionogi launched a consumer website to promote its post-menopausal treatment Osphena. The site features actress Virginia Madsen and is designed as a forum for women to discuss the painful sex condition dyspareunia. Report

Suggested Articles

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.